tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Debjit Chattopadhyay, 182 are a BUY (91.46%), 17 are a HOLD (8.54%).
Analyst Debjit Chattopadhyay, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 48.57% that have a potential upside of 37.89% achieved within 331 days.
Debjit Chattopadhyay’s has documented 410 price targets and ratings displayed on 39 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CNTA, Centessa Pharmaceuticals PLC ADR at 05-Oct-2025.
Analyst best performing recommendations are on HARP (HARPOON THERAPEUTICS).
The best stock recommendation documented was for MGNX (MACROGENICS) at 5/6/2020. The price target of $22 was fulfilled within 1 day with a profit of $3.15 (12.52%) receiving and performance score of 125.25.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$80
$18.44 (29.95%)
$65
13 days ago
(01-Oct-2025)
2/4 (50%)
$25.5 (46.79%)
157
Buy
$76
$14.44 (23.46%)
$35
20 days ago
(24-Sep-2025)
6/7 (85.71%)
$23.35 (44.35%)
102
Buy
$60
$-1.56 (-2.53%)
$20
20 days ago
(24-Sep-2025)
5/5 (100%)
$7.35 (13.96%)
138
Buy
$95
$33.44 (54.32%)
$28
20 days ago
(24-Sep-2025)
11/13 (84.62%)
$42.35 (80.44%)
951
Buy
$80
$18.44 (29.95%)
$58
20 days ago
(24-Sep-2025)
3/5 (60%)
$27.35 (51.95%)
350
Which stock is Debjit Chattopadhyay is most bullish on?
Which stock is Debjit Chattopadhyay is most reserved on?
What Year was the first public recommendation made by Debjit Chattopadhyay?
